Track Asston Pharmaceuticals Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.
1 Week returns: -1.25 %
Low
79.0
High
85.0
1 Month returns: 3.27 %
Low
60.0
High
85.0
1 Year returns: -28.18 %
Low
60.0
High
111.8
3 Year CAGR: –
5 Year CAGR: –
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
Multi-year trends for Asston Pharmaceuticals Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.
Asston Pharmaceuticals Ltd. Shareholding Pattern
Quarterly breakdown of Asston Pharmaceuticals Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.
Bulk, Block and Insider Trades
Recent bulk deals, block deals, and insider trading activity in Asston Pharmaceuticals Ltd. shares as reported to NSE and BSE.
Frequently Asked Questions
What is the current share price of Asston Pharmaceuticals Ltd.?
The current share price of Asston Pharmaceuticals Ltd. is ₹ 79.00 as of 12 Aug 2026.
What is the market capitalisation of Asston Pharmaceuticals Ltd.?
The market capitalisation of Asston Pharmaceuticals Ltd. stands at ₹ 67.24 Cr.
What is the PE ratio of Asston Pharmaceuticals Ltd.?
The Price-to-Earnings (PE) ratio of Asston Pharmaceuticals Ltd. is 17.40 as of the latest trailing twelve months data.
What is the ROE and ROCE of Asston Pharmaceuticals Ltd.?
Asston Pharmaceuticals Ltd. has a Return on Equity (ROE) of 15.59% and a Return on Capital Employed (ROCE) of -2.87% as per the latest financial reports.
What is the 52-week high and low of Asston Pharmaceuticals Ltd.?
The 52-week high of Asston Pharmaceuticals Ltd. is - and the 52-week low is -.
What is the dividend yield of Asston Pharmaceuticals Ltd.?
The dividend yield of Asston Pharmaceuticals Ltd. is 0.00% based on the current market price.
What is the FII and DII holding in Asston Pharmaceuticals Ltd.?
Foreign Institutional Investors (FII) hold 1.91%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 44.46% of Asston Pharmaceuticals Ltd. shares.
What sector does Asston Pharmaceuticals Ltd. belong to?
Asston Pharmaceuticals Ltd. operates in the Healthcare sector.
What is the beta of Asston Pharmaceuticals Ltd.?
The beta of Asston Pharmaceuticals Ltd. is -, indicating its price volatility relative to the broader market.
What is the RSI of Asston Pharmaceuticals Ltd.?
The 14-day Relative Strength Index (RSI) of Asston Pharmaceuticals Ltd. is 58.39, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.
Name
Date
Type
Price
Qty.
Value
Dilip Rameshchandra Jagad
17 Jul 2026
sell
₹ 66.55
1.00 lac
-
Minerva Ventures Fund
12 Jun 2026
sell
₹ 64.05
1.34 lac
-
Prakruti R Pali
12 Jun 2026
buy
₹ 78.41
75.00 k
-
Kingsman Wealth Fund Pcc - Kif Ii
01 Jan 2026
sell
₹ 84.12
50.00 k
-
Jsk Securities And Services Private Limited
28 Jul 2025
sell
₹ 123.37
52.00 k
₹ 64.15 lac
Pradip Bishandas Panjabi
21 Jul 2025
sell
₹ 117.67
45.00 k
₹ 52.95 lac
Neha Mishra
18 Jul 2025
sell
₹ 119.66
50.00 k
₹ 59.83 lac
Amit Rajendra Prasad Agarwal
16 Jul 2025
buy
₹ 119.00
59.00 k
₹ 70.21 lac
Mahesh Vishnupant Mulay
16 Jul 2025
buy
₹ 118.91
1.57 lac
₹ 1.87 cr
Neha Mishra
16 Jul 2025
buy
₹ 119.12
50.00 k
₹ 59.56 lac
79.00-1.2 (-1.56%)
-28.18% in past 1 year
Net Revenue FY
Profit After Tax FY
ROE FY
EBITDA FY
Jul 2025
Sep 2025
Mar 2026
Total Promoter
50.66
50.66
50.66
Indian Promoter
50.66
50.66
50.66
Foreign Promoter
-
-
-
Institutions
12.46
6.04
1.91
Mutual Funds / UTI
-
-
-
FI/Bank/Insurance
0.00
0.00
0.00
Govt
-
-
-
FII
9.71
6.04
1.91
Other Institutions
2.76
0.00
0.00
Non-Institution
36.87
43.30
47.42
Bodies Corporate
1.61
3.25
2.96
Others (incl. Retail)
No. of shareholders
35.26
607
40.05
721
44.46
665
No corporate action data available.
Company Profile
Overview of Asston Pharmaceuticals Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.
Asston Pharmaceuticals Limited is an India-based company, which is engaged in the manufacturing and export of both pharmaceutical formulations and nutraceutical products in domestic and various African markets. The Company is engaged in the business of manufacturing and marketing tablets, capsules, oral liquid, external preparations (ointment, cream, gel and lotion), and oral powder (sachet, dry syrup), and others. It also manufactures various pharmaceutical products for different marketers on a loan license or on a contract manufacturing basis. Its business is primarily conducted on a principle-to-principal basis with various marketers. It operates in supplying pharmaceutical products directly to distributors and pharmacies. Its tablets include Aceclofenac Tablets BP 100 mg; Albendazole Tablets USP 400 mg; B-complex Tablets, and more. Its capsules include Amoxicillin Capsules BP 250 / 500 mg; Ampicillin and Cloxacillin Capsules 500 mg; Ampicillin Capsules BP 250 / 500 mg, and others.
Asston Pharmaceuticals Limited is an India-based company, which is engaged in the manufacturing and export of both pharmaceutical formulations and nutraceutical products in domestic and various African markets. The Company is engaged in the business of manufacturing and marketing tablets, capsules, ...